- Home
- SYBX vs KXIN Comparison
SYBX vs KXIN Comparison
Compare SYBX & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- KXIN
- Stock Information
- Founded
- SYBX N/A
- KXIN 2015
- Country
- SYBX United States
- KXIN China
- Employees
- SYBX N/A
- KXIN N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- SYBX Health Care
- KXIN Consumer Discretionary
- Exchange
- SYBX Nasdaq
- KXIN Nasdaq
- Market Cap
- SYBX 13.6M
- KXIN 13.0M
- IPO Year
- SYBX N/A
- KXIN N/A
- Fundamental
- Price
- SYBX $1.20
- KXIN $0.88
- Analyst Decision
- SYBX
- KXIN
- Analyst Count
- SYBX 0
- KXIN 0
- Target Price
- SYBX N/A
- KXIN N/A
- AVG Volume (30 Days)
- SYBX 6.9K
- KXIN 93.5K
- Earning Date
- SYBX 08-07-2025
- KXIN 01-01-0001
- Dividend Yield
- SYBX N/A
- KXIN N/A
- EPS Growth
- SYBX N/A
- KXIN N/A
- EPS
- SYBX 0.21
- KXIN N/A
- Revenue
- SYBX N/A
- KXIN N/A
- Revenue This Year
- SYBX N/A
- KXIN N/A
- Revenue Next Year
- SYBX N/A
- KXIN N/A
- P/E Ratio
- SYBX $5.92
- KXIN N/A
- Revenue Growth
- SYBX N/A
- KXIN N/A
- 52 Week Low
- SYBX $0.90
- KXIN $0.64
- 52 Week High
- SYBX $1.88
- KXIN $29.54
- Technical
- Relative Strength Index (RSI)
- SYBX 54.75
- KXIN 43.89
- Support Level
- SYBX $1.18
- KXIN $0.89
- Resistance Level
- SYBX $1.27
- KXIN $1.00
- Average True Range (ATR)
- SYBX 0.05
- KXIN 0.07
- MACD
- SYBX -0.00
- KXIN -0.00
- Stochastic Oscillator
- SYBX 58.33
- KXIN 13.88
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.